Company / Net Debt per Share
PUMA BIOTECHNOLOGY, INC. Net Debt per Share History
FY2017-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Debt per Share
-$1.00
FY2024
5-year range
-$1.00 / $0.85
FY2020-FY2024
Trend
-144.1%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Net Debt per Share has declined for 3 consecutive years, from $0.85 in FY2021 to $-1.00 in FY2024.
Based on SEC 10-K filings.
-1.00 in FY2024.
Improved from $0.54 to $-1.00 over the past 2 years.
Net Debt per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- PUMA BIOTECHNOLOGY, INC.'s net debt per share has declined for 3 consecutive years.
- In FY2024, net debt per share decreased 144.1% year-over-year.
- Peak net debt per share was recorded in FY2018.
Annual data
| Year | Net Debt per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | -$1.00 | -144.1% |
| FY2023 | -$0.41 | -176.1% |
| FY2022 | $0.54 | -36.6% |
| FY2021 | $0.85 | +2719.3% |
| FY2020 | -$0.03 | -103.5% |
| FY2019 | $0.91 | -21.2% |
| FY2018 | $1.16 | +228.2% |
| FY2017 | -$0.90 | - |
As of FY2024 · SEC 10-K · Updated Jun 28, 2026